Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002017912 - ENDOTHELIN ANTAGONISTS

Publication Number WO/2002/017912
Publication Date 07.03.2002
International Application No. PCT/US2001/027220
International Filing Date 31.08.2001
Chapter 2 Demand Filed 21.03.2002
IPC
C07D 405/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
CPC
A61P 9/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
12Antihypertensives
C07D 405/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
04directly linked by a ring-member-to-ring-member bond
Applicants
  • ABBOTT LABORATORIES [US]/[US]
Inventors
  • WINN, Martin
  • BOYD, Steven, A.
  • HUTCHINS, Charles, W.
  • HWAN-SOO, Jae
  • TASKER, Andrew, S.
  • VON GELDERN, Tomas, W.
  • KESTER, Jeffrey
  • SORENSEN, Bryan, K.
  • SZCZEPANKIEWICZ, Bruce, G.
  • HENRY, Kenneth
  • LIU, Gang
  • WITTENBERGER, Steven, J.
  • KING, Steven, A.
  • JANUS, Todd, J.
  • PADLEY, Robert, J.
Agents
  • DONNER, B., Gregory
Priority Data
09/653,56331.08.2000US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ENDOTHELIN ANTAGONISTS
(FR) ANTAGONISTES DE L'ENDOTHELINE
Abstract
(EN)
A compound of the formula (I) or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
(FR)
L'invention concerne un composé correspondant à la formule (I), ou un sel pharmaceutiquement acceptable de ce composé, ainsi que des procédés et des intermédiaires pour la préparation de ce composé. L'invention concerne également un procédé pour lutter contre l'action de l'endothéline.
Latest bibliographic data on file with the International Bureau